Yardley, PA – According to filings with the U.S. Securities and Exchange Commission, Astarte Medical Partners is raising $4,380,325.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Tammi Jantzen played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Astarte Medical Partners

Astarte Medical is the only precision medicine company using software and predictive analytics to improve outcomes during the first 1,000 days of life. With an initial focus on preterm infants, Astarte Medical supports feeding protocols, practice and decision-making in the neonatal ICU with a suite of digital tools and diagnostics designed to standardize feeding, optimize nutrition and quantify gut health.

To learn more about Astarte Medical Partners, visit http://www.astartemedical.com/

Contact:
Tammi Jantzen, Chief Financial Officer
215-595-2016
tammi@astartemedical.com
https://www.linkedin.com/in/tammi-jantzen/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved